Detalhe da pesquisa
1.
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
Proc Natl Acad Sci U S A
; 114(19): 4993-4998, 2017 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28446615
2.
Disruption of CHTF18 causes defective meiotic recombination in male mice.
PLoS Genet
; 8(11): e1002996, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23133398
3.
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
Int J Cancer
; 131(4): 956-69, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21918971
4.
Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 18(3): e203-e210, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073681
5.
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.
Science
; 355(6332): 1423-1427, 2017 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28280249
6.
Editor's Note: The Pivotal Role of Integrin ß1 in Metastasis of Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 26(18): 5052, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32934033
7.
Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
PLoS One
; 9(2): e86369, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24586249
8.
RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
Clin Cancer Res
; 19(13): 3416-28, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23719266
9.
Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
Cancer Chemother Pharmacol
; 69(3): 577-90, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21913035
10.
The pivotal role of integrin ß1 in metastasis of head and neck squamous cell carcinoma.
Clin Cancer Res
; 18(17): 4589-99, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22829201
11.
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.
J Control Release
; 159(3): 384-92, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22342644
12.
A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.
ACS Nano
; 5(8): 6184-94, 2011 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21728341
13.
HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.
ACS Nano
; 3(10): 3165-74, 2009 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19761191